Abstract 1723: Application of clinical stage GlycoConnect® technology to bispecific antibodies yields improved bispecific ADCs in comparison to randomly conjugated bsADCs
Year: 2026
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148715558
Cites:
Cited by:
Related to:
